These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 11007557)
41. Comparison of the pulmonary dysfunction caused by cardiogenic and noncardiogenic pulmonary edema. Bernard GR; Pou NA; Coggeshall JW; Carroll FE; Snapper JR Chest; 1995 Sep; 108(3):798-803. PubMed ID: 7656636 [TBL] [Abstract][Full Text] [Related]
42. Effect of beta3-adrenergic agonists on alveolar fluid clearance in hypoxic rat lungs. Li NJ; Li W; He P; Gu X; Li SQ Chin Med J (Engl); 2010 Apr; 123(8):1028-33. PubMed ID: 20497709 [TBL] [Abstract][Full Text] [Related]
43. beta-adrenergic stimulation restores rat lung ability to clear edema in ventilator-associated lung injury. SaldÃas FJ; Lecuona E; Comellas AP; Ridge KM; Rutschman DH; Sznajder JI Am J Respir Crit Care Med; 2000 Jul; 162(1):282-7. PubMed ID: 10903255 [TBL] [Abstract][Full Text] [Related]
44. Salmeterol and inhaled corticosteroids in patients with persistent asthma. Fowler SJ; Lipworth BJ JAMA; 2001 Dec; 286(24):3076-7; author reply 3077-8. PubMed ID: 11754665 [No Abstract] [Full Text] [Related]
45. Salmeterol and inhaled corticosteroids in patients with persistent asthma. Miller FG; Shorr AF JAMA; 2001 Dec; 286(24):3075-6; author reply 3077-8. PubMed ID: 11754663 [No Abstract] [Full Text] [Related]
46. Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha). Finney PA; Donnelly LE; Belvisi MG; Chuang TT; Birrell M; Harris A; Mak JC; Scorer C; Barnes PJ; Adcock IM; Giembycz MA Br J Pharmacol; 2001 Mar; 132(6):1261-70. PubMed ID: 11250877 [TBL] [Abstract][Full Text] [Related]
47. Salmeterol and inhaled corticosteroids in patients with persistent asthma. Friedman Ross L JAMA; 2001 Dec; 286(24):3076; author reply 3077-8. PubMed ID: 11754664 [No Abstract] [Full Text] [Related]
48. Salmeterol and inhaled corticosteroids in patients with persistent asthma. Botkin JR; Clayton E; Nelson R; Wilfond B; Munger MA JAMA; 2001 Dec; 286(24):3075; author reply 3077-8. PubMed ID: 11754662 [No Abstract] [Full Text] [Related]
49. A word of caution regarding a new long-acting bronchodilator. Bone RC JAMA; 1994 May; 271(18):1447-8. PubMed ID: 7909854 [No Abstract] [Full Text] [Related]
50. [New studies refute steroid opponents. COPD--after all a case for corticosteroids?]. Calverley P MMW Fortschr Med; 2003 Jun; 145(24):20. PubMed ID: 12866294 [No Abstract] [Full Text] [Related]
51. Salmeterol. Med Lett Drugs Ther; 1994 Apr; 36(921):37-9. PubMed ID: 7909139 [No Abstract] [Full Text] [Related]
52. The beta-agonist lung injury trial (BALTI). Effros RM Am J Respir Crit Care Med; 2006 Jun; 173(11):1290; author reply 1291-2. PubMed ID: 16738263 [No Abstract] [Full Text] [Related]
54. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids. Chan J; Hui RL; Spence MM J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833 [TBL] [Abstract][Full Text] [Related]
56. Salmeterol xinafoate vs albuterol in asthma: was race a factor? Olopade CO JAMA; 1994 Nov 23-30; 272(20):1576. PubMed ID: 7966862 [No Abstract] [Full Text] [Related]
57. The beta-agonist lung injury trial (BALTI) and the measurement of extravascular lung water. Frost P; Wise M Am J Respir Crit Care Med; 2006 Jun; 173(11):1290-1291; author reply 1291-2. PubMed ID: 16738264 [No Abstract] [Full Text] [Related]
58. [Serevent in the treatment of moderate bronchial asthma]. Panghea P; Voicu G; Filip G; Arghir O; Floca L; Acasandri E; Mihai D Pneumoftiziologia; 1996; 45(3-4):145-8. PubMed ID: 9221040 [TBL] [Abstract][Full Text] [Related]
59. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate. Mahler DA; Waterman LA; Ward J; Gifford AH J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526 [TBL] [Abstract][Full Text] [Related]
60. Preliminary evidence that hydrostatic edema may contribute to the formation of diffuse alveolar damage in a Holstein calf model. Neary JM; Church D F1000Res; 2018; 7():374. PubMed ID: 30555684 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]